Jul 16, 2020 | Video Transcripts
Key opinion leaders discuss trials focusing on patient populations with newly diagnosed chronic lymphocytic leukemia (CLL). Alison Duffy, PharmD, BCOP: I’d love to hear your thoughts on other treatment options besides ibrutinib in a newly diagnosed setting and...
Jul 16, 2020 | Video Transcripts
Experts in the field of chronic lymphocytic management (CLL) consider how MRD (minimum residual disease) testing affects the use of limited duration therapy. Alison Duffy, PharmD, BCOP: What are your thoughts on the limited duration of therapy based on some of the...